Clinical laboratories have always been in the hunt of patient management solutions. In the Canadian market, their search ends at Sysmex Canada, inc., a leading diagnostic solutions company. Sysmex Canada, Inc., is a wholly owned subsidiary of Sysmex America, which offers hematology, urinalysis and flow cytometry testing technology that improves the performance of clinical laboratories. In the recent development, Sysmex Canada has appointed Ian Heynen as the general manager of the company. Ian has been assigned the duties to execute the company’s business strategy in the Canadian market overseeing all aspects of operations including marketing, sales, and technical service functions while leveraging the core strengths and shared services of Sysmex America.
Ian Heynen is a seasoned professional who brings more than 15 years of leadership experience working with healthcare companies. In his last job as senior vice president of sales and marketing for Profound Medical Corp, he led commercial teams to grow global sales by opening new and expanding existing markets. He was also responsible for developing direct and distributor-based sales channels including Philips and Siemens MRI partnerships. Ian has also worked as acting president of the international division of Hologic, Inc., where he was liable for revenue across Hologic’s Breast Health, surgical, and diagnostics businesses in all regions outside of the United States. He will report to Andy Hay, Chief Executive Officer of Sysmex Canada.
Andy Hay, chief executive officer of Sysmex Canada, says, “Ian is a strong leader with a successful track record of delivering business results.” He further adds, “The combination of his passion for growing teams and his healthcare experience will aid Sysmex in bringing to market new products that equip patients, and the healthcare professionals who treat them, with the information needed to make decisions with greater trust and confidence.”